Literature DB >> 33122099

Sonodynamic therapy-derived multimodal synergistic cancer therapy.

Mimi Xu1, Liqiang Zhou2, Lei Zheng3, Qiang Zhou4, Kai Liu5, Yuhang Mao6, Shasha Song7.   

Abstract

Sonodynamic therapy (SDT) represents a promising modality that provides the possibility of non-invasively eliminating solid tumors in a site-directed manner. In light of the complexity and heterogeneity of tumors, more and more studies are attempting to combine SDT with other therapeutic methods so as to achieve better tumor treatment effect, which sheds new light on the potential of SDT-based synergistic therapeutics. Herein, the representative studies of SDT-instructed multimodal synergistic cancer therapy are comprehensively presented, such as sono-chemotherapy, sono-radiotherapy, sono-immunotherapy, and sono-chemodynamic therapy, etc., and their incorporate mechanisms are discussed in detail. The current challenges and future prospects to promote the advanced development of SDT-based nanomedicines in this burgeoning research field are highlighted. It is believed that such an emerging synergistic therapeutic modality based on SDT will play a more significant role in the field of tumor precision treatment medicine.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer treatment; Nanomedicine; Sonodynamic therapy; Synergistic therapy; Ultrasound

Year:  2020        PMID: 33122099     DOI: 10.1016/j.canlet.2020.10.037

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

Review 1.  Current status and future perspective of sonodynamic therapy for cancer.

Authors:  Atsushi Sofuni; Takao Itoi
Journal:  J Med Ultrason (2001)       Date:  2022-10-12       Impact factor: 1.878

2.  One-Step Fabrication of Multifunctional PLGA-HMME-DTX@MnO2 Nanoparticles for Enhanced Chemo-Sonodynamic Antitumor Treatment.

Authors:  Jin Cao; Mingxue Zheng; Zhenyan Sun; Zhiye Li; Xueyong Qi; Song Shen
Journal:  Int J Nanomedicine       Date:  2022-06-07

3.  Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer.

Authors:  Yiran Si; Jian Yue; Zhaoyang Liu; Mo Li; Feng Du; Xue Wang; Zhong Dai; Nanlin Hu; Jie Ju; Songlin Gao; Xiaobing Wang; Peng Yuan
Journal:  Int J Nanomedicine       Date:  2021-03-05

Review 4.  Targeting regulated cell death in tumor nanomedicines.

Authors:  Qinghu Zeng; Xiangyi Ma; Yangmeihui Song; Qiqing Chen; Qiuling Jiao; Liqiang Zhou
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

5.  RNA-Seq Explores the Mechanism of Oxygen-Boosted Sonodynamic Therapy Based on All-in-One Nanobubbles to Enhance Ferroptosis for the Treatment of HCC.

Authors:  Yichi Chen; Haitao Shang; Chunyue Wang; Jiaqi Zeng; Shentao Zhang; Bolin Wu; Wen Cheng
Journal:  Int J Nanomedicine       Date:  2022-01-07

Review 6.  Magnetic mediators for ultrasound theranostics.

Authors:  Arkadiusz Józefczak; Katarzyna Kaczmarek; Rafał Bielas
Journal:  Theranostics       Date:  2021-11-02       Impact factor: 11.556

7.  Microbubbles Ultrasonic Cavitation Regulates Tumor Interstitial Fluid Pressure and Enhances Sonodynamic Therapy.

Authors:  Fen Xi; Yuyi Feng; Qiaoli Chen; Liping Chen; Jianhua Liu
Journal:  Front Oncol       Date:  2022-04-26       Impact factor: 5.738

8.  Construction of ultrasound-responsive urokinase precise controlled-release nanoliposome applied for thrombolysis.

Authors:  Yongliang Fan; Li Liu; Fang Li; Hang Zhou; Yizhou Ye; Chunping Yuan; Hongli Shan; Wangfu Zang; Yu Luo; Sijing Yan
Journal:  Front Bioeng Biotechnol       Date:  2022-08-09

Review 9.  Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death.

Authors:  Feiyang Jin; Di Liu; Xiaoling Xu; Jiansong Ji; Yongzhong Du
Journal:  Int J Nanomedicine       Date:  2021-07-08

Review 10.  Current Landscape of Sonodynamic Therapy for Treating Cancer.

Authors:  Toshihiro Yamaguchi; Shuji Kitahara; Kaori Kusuda; Jun Okamoto; Yuki Horise; Ken Masamune; Yoshihiro Muragaki
Journal:  Cancers (Basel)       Date:  2021-12-08       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.